Stock 4553 TOWA PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Towa Pharmaceutical Co., Ltd.

Equities

4553

JP3623150004

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
2,773 JPY -0.11% Intraday chart for Towa Pharmaceutical Co., Ltd. +0.84% +17.90%
Mar. 25 Towa Pharmaceutical Completes Payment for Director Stock Compensation MT
Mar. 07 VIE STYLE, Inc. announced that it has received ¥305 million in funding from Otsuka Holdings Co., Ltd., KAYAC Inc., Taisho Pharmaceutical Holdings Co., Ltd., Towa Pharmaceutical Co., Ltd., PE&HR Co., Ltd., Murata Manufacturing Co., Ltd. and other investors CI

Business Summary

Towa Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The main products are generic drugs, which are launched after the efficacy and safety of new drugs have been confirmed for a certain period of time. It is a drug with the same effect, usage and dosage. The Company is involved in the sale and outsourced manufacture of products and generic drugs. The Company is involved in the research and outsourced manufacture of active pharmaceutical ingredient and soft capsules. The Company is also involved in the planning, development, contract manufacturing of health foods, general foods, miscellaneous goods and others.

Number of employees: 4,298

Sales per Business

JPY in Million2022Weight2023Weight Delta
Manufacture and Distribution of Pharmaceutical
100.0 %
165,615 100.0 % 208,859 100.0 % +26.11%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
74.5 %
126,676 76.5 % 155,538 74.5 % +22.78%
Overseas
25.5 %
38,938 23.5 % 53,321 25.5 % +36.94%

Managers

Managers TitleAgeSince
Itsuro Yoshida PSD
 President 73 79-04-30
Kenichi Inoue ADM
 Chief Administrative Officer - -
Norikazu Inoue BRD
 Director/Board Member - -
Osamu Uchikawa BRD
 Director/Board Member - -
Masao Tanaka BRD
 Director/Board Member 69 09-03-31
Shigehiro Kubo SEC
 Corporate Secretary - -
Takeshi Sugiura PRN
 Corporate Officer/Principal - -
Shinya Kida AUD
 Comptroller/Controller/Auditor - -
Hiroyuki Oe HRO
 Human Resources Officer - -
Kunio Sasaki AUD
 Comptroller/Controller/Auditor - -

Members of the board

Members of the board TitleAgeSince
Itsuro Yoshida PSD
 President 73 79-04-30
Sadayuki Morino PRN
 Corporate Officer/Principal 70 81-08-31
Norikazu Eiki BRD
 Director/Board Member 76 15-05-31
Yasushi Naito SAM
 Sales & Marketing 60 90-03-31
Masao Tanaka BRD
 Director/Board Member 69 09-03-31
Kaori Oishi BRD
 Director/Board Member 47 20-06-23
Kenryo Goto BRD
 Director/Board Member - 21-06-24
Osamu Uchikawa BRD
 Director/Board Member - -
Norikazu Inoue BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 51,516,000 24,448,973 ( 47.46 %) 2,296,786 ( 4.458 %) 47.46 %

Shareholders

NameEquities%Valuation
Yoshida Family
39.02 %
20,100,000 39.02 % 386 M ¥
TOWA PHARMACEUTICAL CO., LTD.
4.458 %
2,296,700 4.458 % 44 M ¥
Towa Pharmaceutical Business Association
2.939 %
1,514,000 2.939 % 29 M ¥
Itsuro Yoshida
2.824 %
1,455,000 2.824 % 28 M ¥
Guardians of New Zealand Superannuation
1.962 %
1,010,758 1.962 % 19 M ¥
Towa Pharmaceutical Employee Stock Ownership Plan
1.875 %
966,000 1.875 % 19 M ¥
Yoshida Estate YK
1.258 %
648,000 1.258 % 12 M ¥
Nippon Life Insurance Co.
0.8502 %
438,000 0.8502 % 8 M ¥
DAI-ICHI LIFE HOLDINGS, INC.
0.8444 %
435,000 0.8444 % 8 M ¥
Argenta Spaarbank NV
0.7512 %
387,000 0.7512 % 7 M ¥

Holdings

NameEquities%Valuation
TOWA PHARMACEUTICAL CO., LTD.
4.46%
 2,296,700 4.46% 44,068,965 $
MITSUBISHI UFJ FINANCIAL GROUP, INC
0.00%
 147,040 0.00% 1,512,711 $
DAITO PHARMACEUTICAL CO.,LTD.
0.39%
 60,500 0.39% 937,011 $
MIZUHO FINANCIAL GROUP, INC.
0.00%
 4,200 0.00% 84,530 $

Company contact information

Towa Pharmaceutical Co., Ltd.

2-11 Shinbashi-cho

571-8580, Kadoma

+81 6 6900 9100

http://www.towayakuhin.co.jp
address Towa Pharmaceutical Co., Ltd.(4553)

Group companies

NameCategory and Sector
Dose Innova SL
Towa Pharma International Holdings SL (Sociedad Unipersonal)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Towa Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2,773 JPY
Average target price
3,690 JPY
Spread / Average Target
+33.07%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
TOWA PHARMACEUTICAL CO., LTD. Stock Towa Pharmaceutical Co., Ltd.
+17.90% 867M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4553 Stock
  4. Company Towa Pharmaceutical Co., Ltd.